...
thrd-img

Third Harmonic Bio Inc., Common Stock

THRD

NMQ

$11.115

-$0.23

(-2.03%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$511.41M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
183.44K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.86
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$8.07 L
$16.94 H
$11.115

About Third Harmonic Bio Inc., Common Stock

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTHRDSectorS&P500
1-Week Return-9.85%-3.39%0.2%
1-Month Return-1.3%-1.92%2.72%
3-Month Return-10.98%-10.54%7.31%
6-Month Return-12.36%-4.47%10.44%
1-Year Return14.65%4.06%27.53%
3-Year Return-33.24%0.94%30.88%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue--38.00K35.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.11,"profit":true}]
Gross Profit--(38.00K)(35.00K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3800000,"profit":false},{"date":"2023-12-31","value":-3500000,"profit":false}]
Gross Margin--(Infinity%)(Infinity%)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses11.12M19.00M37.71M43.95M[{"date":"2020-12-31","value":25.3,"profit":true},{"date":"2021-12-31","value":43.24,"profit":true},{"date":"2022-12-31","value":85.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(11.12M)(19.00M)(37.71M)(43.95M)[{"date":"2020-12-31","value":-1111900000,"profit":false},{"date":"2021-12-31","value":-1900400000,"profit":false},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":-4395400000,"profit":false}]
Total Non-Operating Income/Expense--5.11M26.24M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":19.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(12.81M)(29.61M)(35.16M)(30.82M)[{"date":"2020-12-31","value":-1280800000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3515500000,"profit":false},{"date":"2023-12-31","value":-3082400000,"profit":false}]
Income Taxes(1.00K)10.61M2.55M-[{"date":"2020-12-31","value":-0.01,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.07,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes--(37.71M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.81M)(29.61M)(35.16M)(35.48M)[{"date":"2020-12-31","value":-1280800000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3515500000,"profit":false},{"date":"2023-12-31","value":-3547800000,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(12.81M)(29.61M)(37.71M)(30.82M)[{"date":"2020-12-31","value":-1280700000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":-3082400000,"profit":false}]
EPS (Diluted)--(1.22)(0.98)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-122,"profit":false},{"date":"2023-12-31","value":-98,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

THRD
Cash Ratio 41.91
Current Ratio 42.50

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

THRD
ROA (LTM) -11.26%
ROE (LTM) -13.81%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

THRD
Debt Ratio Lower is generally better. Negative is bad. 0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.97

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

THRD
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.73
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Third Harmonic Bio Inc. share price today?

Third Harmonic Bio Inc. (THRD) share price today is $11.115

Can Indians buy Third Harmonic Bio Inc. shares?

Yes, Indians can buy shares of Third Harmonic Bio Inc. (THRD) on Vested. To buy Third Harmonic Bio Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in THRD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Third Harmonic Bio Inc. be purchased?

Yes, you can purchase fractional shares of Third Harmonic Bio Inc. (THRD) via the Vested app. You can start investing in Third Harmonic Bio Inc. (THRD) with a minimum investment of $1.

How to invest in Third Harmonic Bio Inc. shares from India?

You can invest in shares of Third Harmonic Bio Inc. (THRD) via Vested in three simple steps:

  • Click on Sign Up or Invest in THRD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Third Harmonic Bio Inc. shares
What is Third Harmonic Bio Inc. 52-week high and low stock price?

The 52-week high price of Third Harmonic Bio Inc. (THRD) is $16.94. The 52-week low price of Third Harmonic Bio Inc. (THRD) is $8.07.

What is Third Harmonic Bio Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Third Harmonic Bio Inc. (THRD) is

What is Third Harmonic Bio Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Third Harmonic Bio Inc. (THRD) is 1.73

What is Third Harmonic Bio Inc. dividend yield?

The dividend yield of Third Harmonic Bio Inc. (THRD) is 0.00%

What is the Market Cap of Third Harmonic Bio Inc.?

The market capitalization of Third Harmonic Bio Inc. (THRD) is $511.41M

What is Third Harmonic Bio Inc.’s stock symbol?

The stock symbol (or ticker) of Third Harmonic Bio Inc. is THRD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top